Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brivio

Showing results (71-80 of 321) with videos related to

Pageof 33
Sort By:
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
In Vivo (Athens, Greece)|May 13, 2008
Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancerP Lissoni, G Messina, A Balestra, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Is there a role for melatonin in the treatment of neoplastic cachexia?P Lissoni, F Paolorossi, G Tancini, et al.
Il Giornale Di Chirurgia|December 3, 1998
[Variations in interleukin-2 and interleukin-6 due to surgical trauma in cancer patients]F Brivio, M Perego, E Mauri, et al.
The International Journal of Biological Markers|July 17, 2008
Correlation between soluble IL-2 receptor serum levels and regulatory T lymphocytes in patients with solid tumorsF Brivio, P Lissoni, L Fumagalli, et al.
Tumori|August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapyP Lissoni, S Barni, G Tancini, et al.
In Vivo (Athens, Greece)|October 16, 2008
A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patientsP Lissoni, G Messina, D Parolini, et al.
Anticancer Research|November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotensionP Lissoni, F Brivio, S Barni, et al.
Pageof 33

Showing results (71-80 of 321) with videos related to

Sort By:
Pageof 33
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Oncology|November 1, 1995
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretionP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
In Vivo (Athens, Greece)|May 13, 2008
Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancerP Lissoni, G Messina, A Balestra, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Is there a role for melatonin in the treatment of neoplastic cachexia?P Lissoni, F Paolorossi, G Tancini, et al.
Il Giornale Di Chirurgia|December 3, 1998
[Variations in interleukin-2 and interleukin-6 due to surgical trauma in cancer patients]F Brivio, M Perego, E Mauri, et al.
The International Journal of Biological Markers|July 17, 2008
Correlation between soluble IL-2 receptor serum levels and regulatory T lymphocytes in patients with solid tumorsF Brivio, P Lissoni, L Fumagalli, et al.
Tumori|August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapyP Lissoni, S Barni, G Tancini, et al.
In Vivo (Athens, Greece)|October 16, 2008
A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patientsP Lissoni, G Messina, D Parolini, et al.
Anticancer Research|November 1, 1990
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotensionP Lissoni, F Brivio, S Barni, et al.
Pageof 33